Cargando...
5PSQ-016 Safe use of antiplatelet medication: approaching the optimal dose of aspirin by pharmaceutical intervention
BACKGROUND: Based on available evidence and its benefit/risk balance, acetylsalicylic acid (ASA) is the first-line antiplatelet drug of choice for secondary prevention of cardiovascular events. It is recommended to be used at low doses, not exceeding 150 mg/day. This dosage has proved to be effectiv...
Gardado en:
| Publicado en: | Eur J Hosp Pharm |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMJ Group
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535577/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.370 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|